Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI AG
Citação
VIRUSES-BASEL, v.8, n.2, article ID 38, 17p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Human T-cell leukemia virus type 1 (HTLV-1), hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) are prevalent worldwide, and share similar means of transmission. These infections may influence each other in evolution and outcome, including cancer or immunodeficiency. Many studies have reported the influence of genetic markers on the host immune response against different persistent viral infections, such as HTLV-1 infection, pointing to the importance of the individual genetic background on their outcomes. However, despite recent advances on the knowledge of the pathogenesis of HTLV-1 infection, gaps in the understanding of the role of the individual genetic background on the progress to disease clinically manifested still remain. In this scenario, much less is known regarding the influence of genetic factors in the context of dual or triple infections or their influence on the underlying mechanisms that lead to outcomes that differ from those observed in monoinfection. This review describes the main factors involved in the virus-host balance, especially for some particular human leukocyte antigen (HLA) haplotypes, and other important genetic markers in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and other persistent viruses, such as HIV and HCV.
Palavras-chave
HTLV-1, HIV-1, HCV, genetic factors
Referências
  1. Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06
  2. An P, 2014, J INFECT DIS, V210, P1539, DOI 10.1093/infdis/jiu291
  3. KOZIEL MJ, 1992, J IMMUNOL, V149, P3339
  4. Teixeira SLM, 2014, GENES IMMUN, V15, P256, DOI 10.1038/gene.2014.14
  5. de Vasconcelos JM, 2013, GENET MOL BIOL, V36, P22, DOI 10.1590/S1415-47572013000100004
  6. Sobesky M, 2000, PRESSE MED, V29, P413
  7. Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
  8. Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229
  9. Machmach K, 2013, J INFECT DIS, V207, P651, DOI 10.1093/infdis/jis717
  10. Deschamps R, 2010, INT J INFECT DIS, V14, pE986, DOI 10.1016/j.ijid.2010.05.020
  11. BARTHOLOMEW C, 1987, LANCET, V2, P1469
  12. Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135
  13. MAGNANI G, 1995, INFECTION, V23, P63, DOI 10.1007/BF01710063
  14. Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948
  15. Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399
  16. Stewart GJ, 1997, AIDS, V11, P1833, DOI 10.1097/00002030-199715000-00007
  17. Casoli C, 2000, BLOOD, V95, P2760
  18. Sanabani SS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-374
  19. Nasi M, 2013, INT J INFECT DIS, V17, pE845, DOI 10.1016/j.ijid.2013.01.003
  20. Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845
  21. Sabouri AH, 2005, J GEN VIROL, V86, P773, DOI 10.1099/vir.0.80509-0
  22. Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/01.aids.0000096870.36052.b6
  23. Martin AM, 2004, P NATL ACAD SCI USA, V101, P4180, DOI 10.1073/pnas.0307067101
  24. Singh KK, 2005, J INFECT DIS, V191, P1971, DOI 10.1086/430091
  25. [Anonymous], 2012, VIROL J, DOI 10.1186/1743-422X-9-40
  26. Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670
  27. Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6
  28. Cole AM, 2003, CURR PHARM DESIGN, V9, P1463, DOI 10.2174/1381612033454667
  29. Beilke MA, 2004, CLIN INFECT DIS, V39, P256, DOI 10.1086/422146
  30. Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146
  31. Lewis MJ, 2000, J IMMUNOL, V165, P4127
  32. Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X
  33. Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489
  34. Jacobson Steven, 1997, Leukemia (Basingstoke), V11, P73
  35. Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200
  36. Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848
  37. Brites C, 2009, AIDS REV, V11, P8
  38. Ballana E, 2012, IMMUNOBIOLOGY, V217, P889, DOI 10.1016/j.imbio.2011.12.012
  39. Phillips EJ, 2005, AIDS, V19, P979, DOI 10.1097/01.aids.0000171414.99409.fb
  40. Balistrieri G, 2013, VIRAL IMMUNOL, V26, P3, DOI 10.1089/vim.2012.0060
  41. [Anonymous], 2010, J TRANSL MED S1, DOI 10.1186/1479-5876-9-S1-S9
  42. Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463
  43. Trevino A, 2012, CLIN INFECT DIS, V55, pE1, DOI 10.1093/cid/cis343
  44. Chatterjee A, 2012, DIS MARKERS, V32, P143, DOI 10.3233/DMA-2011-0874
  45. Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X
  46. Cocchi F, 2000, P NATL ACAD SCI USA, V97, P13812, DOI 10.1073/pnas.240469997
  47. Jeffery KJM, 2000, J IMMUNOL, V165, P7278
  48. Bangham CRM, 1999, PHILOS T ROY SOC B, V354, P691, DOI 10.1098/rstb.1999.0422
  49. Gong XH, 2015, INFECT GENET EVOL, V34, P137, DOI 10.1016/j.meegid.2015.07.012
  50. Smith MW, 1997, NAT MED, V3, P1052, DOI 10.1038/nm1097-1052c
  51. Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274
  52. Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1
  53. Numasaki M, 2007, J IMMUNOL, V178, P5086
  54. Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004
  55. Gao XJ, 2010, AIDS, V24, P1835, DOI 10.1097/QAD.0b013e32833c3219
  56. Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400
  57. Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874
  58. Ruggero K, 2010, MOL ASPECTS MED, V31, P367, DOI 10.1016/j.mam.2010.05.001
  59. Hendel H, 1999, J IMMUNOL, V162, P6942
  60. COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000
  61. Montanheiro PA, 2009, SCAND J IMMUNOL, V70, P403, DOI 10.1111/j.1365-3083.2009.02291.x
  62. CIMARELLI A, 1995, J ACQ IMMUN DEF SYND, V10, P198
  63. Goedert JJ, 2007, INT J CANCER, V121, P1092, DOI 10.1002/ijc.22767
  64. Borducchi DM, 2003, BRIT J HAEMATOL, V123, P954, DOI 10.1046/j.1365-2141.2003.04711.x
  65. Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397
  66. de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541
  67. KLEIN MR, 1994, J INFECT DIS, V169, P1244
  68. Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092
  69. Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203
  70. Bassani S, 2007, CLIN INFECT DIS, V44, P105, DOI 10.1086/510076
  71. Ferbas J, 2000, J INFECT DIS, V182, P1247, DOI 10.1086/315849
  72. Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477
  73. Bovolenta C, 2002, BLOOD, V99, P224, DOI 10.1182/blood.V99.1.224
  74. Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856
  75. Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405
  76. Julg B, 2011, J INFECT DIS, V203, P803, DOI 10.1093/infdis/jiq122
  77. Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621
  78. Trevino A, 2013, J NEUROL, V260, P2551, DOI 10.1007/s00415-013-7014-z
  79. Cardoso DF, 2009, REV I MED TROP, V51, P325, DOI [10.1590/S0036-46652009000600004, 10.1590/S0036-46652009000600003]
  80. Schinkel J, 1999, J INFECT DIS, V179, P825, DOI 10.1086/314658
  81. Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100
  82. Michael NL, 1997, LANCET, V350, P741, DOI 10.1016/S0140-6736(05)63552-0
  83. IRVING SG, 1990, NUCLEIC ACIDS RES, V18, P3261, DOI 10.1093/nar/18.11.3261
  84. Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05
  85. Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447
  86. Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
  87. ZACK JA, 1988, SCIENCE, V240, P1026, DOI 10.1126/science.2835813
  88. Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860
  89. Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0
  90. Sato A, 2006, J IMMUNOL, V176, P7686
  91. [Anonymous], 2009, PLOS COMPUT BIOL, DOI 10.1371/JOURNAL.PCBI.1000327
  92. Catalan-Soares BC, 2009, MED MICROBIOL IMMUN, V198, P1, DOI 10.1007/s00430-008-0096-z
  93. Vidal F, 2005, JAIDS-J ACQ IMM DEF, V40, P527, DOI 10.1097/01.qai.0000186362.50457.e0
  94. Weinberg A, 2006, Adv Dent Res, V19, P42
  95. Mohd Hanafiah Khayriyyah, 2013, Hepatology, V57, P1333, DOI 10.1002/hep.26141
  96. Shebl FM, 2011, J INFECT DIS, V204, P1843, DOI 10.1093/infdis/jir647
  97. Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8
  98. Hughes AR, 2004, PHARMACOGENOMICS, V5, P203, DOI 10.1517/phgs.5.2.203.27481
  99. Ullum H, 1998, J INFECT DIS, V177, P331
  100. Antoni G, 2013, AIDS, V27, P1707, DOI 10.1097/QAD.0b013e328360a4bd
  101. Assone T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003199
  102. Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636
  103. De Re V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117420
  104. Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0
  105. Imanishi T., 1992, HLA 1991, P1065
  106. FERRI C, 1994, EUR J CLIN INVEST, V24, P781, DOI 10.1111/j.1365-2362.1994.tb01077.x
  107. Kamihira S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-40
  108. Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52
  109. MacNamara A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001117
  110. Moroni M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0335-6
  111. National Institutes of Health, 2002, GASTROENTEROLOGY, V123, P2082, DOI 10.1053/GAST.2002.1232082
  112. Aka PV, 2014, J INFECT DIS, V209, P350, DOI 10.1093/infdis/jit433
  113. Ramana GV, 2001, J GENET, V80, P137, DOI 10.1007/BF02717909
  114. Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699
  115. Schwartz O, 2007, NAT MED, V13, P245, DOI 10.1038/nm0307-245
  116. Taghaddosi M, 2013, IRAN J BASIC MED SCI, V16, P264
  117. Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347